Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ARAV similar filings
- 2 Aug 23 Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept in Platinum-Resistant Ovarian Cancer
- 5 Jun 23 Regulation FD Disclosure
- 25 May 23 Regulation FD Disclosure
- 16 May 23 Aravive Announces Phase 3 Trial Design for Batiraxcept in Clear Cell Renal Cell Carcinoma
- 10 May 23 Aravive Reports First Quarter 2023 Financial Results and Provides Corporate Updates
- 11 Apr 23 Aravive Appoints Carolina Petrini as Chief Commercial Officer
- 15 Mar 23 Aravive Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
Filing view
External links
Exhibit 99.2